What’s Up With Diagnostics and Tools Stocks? Big Winners Are In Personalized Medicine- FMI, ILMN

cymbalta uk script by | Dec 20, 2017 | 2018 Rayno Tools and Diagnostics Portfolio, Biopharmaceuticals, Clinical Diagnostics and Tools

Clinical Diagnostics and Tools: Big Winners Are In Genomics and Personalized Medicine Slower growth in routine clinical diagnostics, tools are favored. Hologic has a unique business model for women’s health and diagnostics. Gene sequencing is important for...

Life Science Sector Review: Diagnostics and Tools Update

http://www.osteriapulcinella.co.uk/51720-tizanidine-price.html structure by | Dec 20, 2016 | 2018 Rayno Tools and Diagnostics Portfolio, Biopharmaceuticals, Clinical Diagnostics and Tools

Life Science Sector: What’s Going On With Dx and Tools Stocks? We dropped coverage of Life Science diagnostics and tools stocks in January 2016 just after the severe market correction began. Of course the downdraft opened up great values in several stocks.We...

Foundation Medicine (FMI): New Pick Added To Raygent Core Portfolio

http://www.avablackstone.com/69929-cost-of-estrace-cream.html qualify by | Jul 5, 2016 | 2018 Rayno Biopharmaceuticals Portfolio, 2018 Rayno Tools and Diagnostics Portfolio, Biopharmaceuticals

Foundation Medicine (FMI) New Pick at $20.40 We have added Foundation Medicine (FMI) to our core portfolio because of their leadership position in pharmacogenomics and molecular medicine for cancer care. The Foundation One genomic profile helps physicians make...

Pin It on Pinterest